Comparison Overview
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals
Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099
Last Update: 29/04/2026
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

Zoetis
10 Sylvan Way, Parsippany, NJ, US, 07054
Last Update: 04/04/2026
The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock far...
Compliance Ranges Comparison

Glenmark Pharmaceuticals







Zoetis






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Glenmark Pharmaceuticals has 34.64% fewer incidents than the average of same-industry companies with at least one recorded incident.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Zoetis in 2026.
Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)
Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Zoetis (X = Date, Y = Severity)
Zoetis cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Glenmark Pharmaceuticals

Zoetis
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.